Dr. Bipin Savani, MB BS

• Transplant Surgery

• Hematology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Newcastle School Of Medicine

  Medical School, 1989

• English

• Arabic

• Impact of T-cell dose on the outcome of T-cell replete HLA matched allogeneic peripheral blood stem cell transplantation., 2019-05-11

• Female long term survivors after allo-HSCT: evaluation and management, 2011-10-11

• Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMT, 2023-03-31

• Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT), 2019-04-25

• Allogeneic Transplantation to Treat Therapy Related MDS and AML in Adults, 2021-08-21

• Lamivudine Prophylaxis and Hepatitis B Vaccination for Prevention of HBV Reverse Seroconversion in Long Term Survivors after Allogeneic Stem Cell Transplantation, 2013-08-15

• Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation, 2018-01-30

• Minimal residual disease negativity and lenalidomide maintenance therapy are associated with superior survival outcomes in multiple myeloma, 2020-01-28

• Favorable Outcomes in Patients Surviving 5 or More Years after Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies, 2010-03-17

• PROVIDING PERSONALIZED PROGNOSTIC INFORMATION FOR ADULT LEUKEMIA SURVIVORS, 2013-09-06

• RICversusMAC UCBT in adults with AML: A report from Eurocord, the ALWP and the CTIWP of the EBMT, 2016-05-26

• Health Related Quality of Life in Young Adults Survivors of Hematopoietic Cell Transplantation, 2022-07-22

• Salvage Second Hematopoietic Cell Transplantation in Myeloma, 2013-01-05

• THE IMPACT OF GRAFT VERSUS HOST DISEASE ON RELAPSE RATE IN PATIENTS WITH LYMPHOMA DEPENDS ON THE HISTOLOGICAL SUB-TYPE AND THE INTENSITY OF THE CONDITIONING REGIMEN, 2015-05-15

• Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at less than Three Years of Age, 2017-04-28

• Impact of Autologous Blood Transfusion after Bone Marrow Harvest on Unrelated Donor's Health and Outcome: A CIBMTR Analysis, 2020-04-30

• Timing of Allogeneic Hematopoietic Cell Transplantation (AlloHCT) for Chronic Myeloid Leukemia (CML) Patients, 2020-07-14

• Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group, 2019-10-01

• Country-level Macroeconomic Indicators predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis, 2018-03-19

• The Impact of pre-transplant depression on the outcomes of allogeneic and autologous hematopoietic stem cell transplantation, 2017-01-19

• REDUCED INTENSITY HEMATOPOIETIC CELL TRANSPLANTATION FOR PATIENTS WITH PRIMARY MYELOFIBROSIS: A COHORT ANALYSIS FROM THE CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH, 2013-10-23

• Impact of pre-transplant renal dysfunction on outcomes after allogeneic hematopoietic cell transplantation, 2021-02-26

• Second solid cancers after allogeneic hematopoietic cell transplantation using reduced intensity conditioning, 2014-07-17

• Significant improvements in the practice patterns of adult related donor care in US transplant centers, 2015-11-18

• CAR T cell therapy in solid tumors: A review of current clinical trials, 2021-12-07

• Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation, 2015-08-24

• Does recipient body mass index inform donor selection for allogeneic hematopoietic cell transplantation?, 2022-03-14

• Allotransplantation for patients age 40 years and greater with non-Hodgkin Lymphoma (NHL): encouraging progression-free survival, 2014-03-15

• Strategies to Prevent EBV Reactivation and Posttransplant Lymphoproliferative Disorders (PTLD) after Allogeneic Stem Cell Transplantation in High-Risk Patients, 2010-08-21

• National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Developing Recommendations to Improve Survivorship and Long-term Outcomes, 2016-10-29

• Outcomes of Allogeneic Hematopoietic Cell Transplantation for Chronic Neutrophilic Leukemia: A Combined CIBMTR/CMWP of EBMT Analysis, 2022-06-03

• Characteristics of Graft-versus-Host Disease (GvHD) after Post-transplant Cyclophosphamide versus Conventional GvHD Prophylaxis, 2022-07-16

• Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study, 2019-10-25

• Next generation long term transplant clinics: Improving resource utilization and the quality of care through health information technology, 2015-09-14

• Repair of Impaired Pulmonary Function Is Possible in Very-Long-Term Allogeneic Stem Cell Transplantation Survivors, 2013-11-02

• Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia, 2021-05-03

• Survival Outcomes of Allogeneic Hematopoietic Cell Transplants with EBV positive or EBV negative Post Transplant Lymphoproliferative Disorder (PTLD), A CIBMTR Study., 2019-07-31

• BACTERIAL BLOOD STREAM INFECTIONS (BSI), PARTICULARLY POST-ENGRAFTMENT BSI, ARE ASSOCIATED WITH INCREASED MORTALITY AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION, 2018-12-13

• Allogeneic Hematopoietic Cell Transplantation for Advanced Polycythemia Vera and Essential Thrombocythemia, 2012-03-24

• Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party, 2017-01-24

• Classifying Cytogenetics in Patients with AML in Complete Remission Undergoing Allogeneic Transplantation: A CIBMTR Study, 2011-07-31

• Inferior Outcomes with Cyclosporine and Mycophenolate mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation, 2019-05-31

• Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: Impact of tyrosine kinase inhibitor and minimal residual disease, 2013-08-30

• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report, 2015-03-31

• Male Survivors of Allogeneic Hematopoietic Stem Cell Transplantation Have a Long Term Persisting Risk of Cardiovascular Events, 2013-10-17

• Metabolic complications precede alloreactivity and are characterized by changes in ST2 signaling, 2016-12-21

• Sexual Health in Hematopoietic Stem Cell Transplant Recipients, 2015-09-15

• Chimeric antigen receptor-T cell therapies: The changing landscape, 2021-11-29

• Outcomes of rituximab-BEAM vs BEAM conditioning regimen in patients with diffuse large B-cell lymphoma undergoing autologous transplantation., 2020-02-12

• Overview of approved CAR-T therapies, ongoing clinical trials, and its impact on clinical practice, 2021-11-24

• Comparison of Outcomes of Allogeneic Transplantation for CML with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan or TBI, 2014-12-17

• Epigenetic landscape of theTERTpromoter: a potential biomarker for high risk AML/MDS, 2016-07-19

• ALTERNATIVE DONORS EXTEND TRANSPLANTATION FOR PATIENTS WITH LYMPHOMA WHO LACK AN HLA MATCHED DONOR, 2014-11-17

• Donor KIR Genes 2DL5A, 2DS1 and 3DS1 Are Associated with a Reduced Rate of Leukemia Relapse After HLA-Identical Sibling Stem Cell Transplantation for Acute Myeloid Leukemia but Not Other Hematologic Malignancies, 2010-03-17

• Non-infectious pulmonary toxicity after allogeneic hematopoietic cell transplantation, 2022-03-18

• Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States, 2021-04-22

• A Prognostic Model Predicting Autologous Transplantation Outcomes in Children, Adolescents and Young Adults with Hodgkin Lymphoma, 2015-08-03

• Late Effects in Hematopoietic Cell Transplant Recipients with Acquired Severe Aplastic Anemia: A Report from the Late Effects Working Committee of the Center for International Blood and Marrow Transplant Research, 2012-08-01

• The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years-a report from the EBMT acute leukemia working party, 2016-08-03

• SECOND MALIGNANCIES AFTER AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN CHILDREN, 2012-09-10

• Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT, 2016-05-14

• The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor Specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation, 2018-01-15

• Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation, 2015-08-07

• Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement, 2019-05-25

• Long-Term Outcomes Among Two-Year Survivors of Autologous Hematopoietic Cell Transplant for Hodgkin and Diffuse Large B-Cell Lymphoma, 2017-11-10

• Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT), 2019-05-15

• Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: A Center for International Blood and Marrow Transplant Research Analysis, 2017-09-18

• Examining disease boundaries: Genetics of myelodysplastic/myeloproliferative neoplasms, 2021-07-19

• The incidence, mortality and timing ofPneumocystis jirovecipneumonia after hematopoietic cell transplantation: a CIBMTR®analysis, 2016-01-04

• Long-term Survival and Late Effects among 1-year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes, 2014-10-12

• Allogeneic Hematopoietic Cell Transplant for Adult Chronic Myelomonocytic Leukemia, 2017-01-20

• Single- or double-unit UCBT following RIC in adults with AL: a report from Eurocord, the ALWP and the CTIWP of the EBMT, 2017-06-21

• IMPACT OF PRETRANSPLANT CONDITIONING REGIMENS ON OUTCOMES OF ALLOGENEIC TRANSPLANTATION FOR CHEMOTHERAPY-UNRESPONSISVE DIFFUSE LARGE B-CELL LYMPHOMA AND GRADE-III FOLLICULAR LYMPHOMA, 2013-02-01

• Comparison of fludarabine-melphalan and fludarabine-treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party, 2022-05-14

• Effect of post remission therapy prior to reduced intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission, 2013-11-01

• Male-specific late effects in adult hematopoietic cell transplantation recipients a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of, 2021-10-29

• Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma, 2015-10-05

• Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR®study, 2016-12-19

• HLA DR15 Antigen Status Does Not Impact Graft-versus-Host Disease or Survival in HLA-Matched Sibling Transplantation for Hematologic Malignancies, 2012-03-10

• Classic and Overlap Chronic Graft-versus-Host Disease (cGVHD) Is Associated with Superior Outcome after Extracorporeal Photopheresis (ECP), 2009-08-03

• Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improves Transplant Outcomes in Older MDS Patients, 2021-08-14

• Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplant, 2018-10-02

• Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT, 2018-12-03

• New Cancers after Autotransplants for Multiple Myeloma, 2014-12-31

• The concentration of total nucleated cells in harvested bone marrow for transplantation has decreased over time., 2019-02-02

• Allogeneic Haematopoietic Cell Transplantation for Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: A CIBMTR Analysis, 2017-08-02

• Late Cardiovascular Morbidity and Mortality Following Pediatric Allogeneic Hematopoietic Cell Transplantation, 2018-03-26

• Collection of Peripheral Blood Progenitor Cells in One Day is Associated with Decreased Donor Toxicity compared to Two Days in Unrelated Donors., 2020-02-20

• Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries, 2019-09-26

• UNRELATED DONOR ALLOGENEIC TRANSPLANTATION AFTER FAILURE OF AUTOLOGOUS TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA: A STUDY FROM THE CIBMTR, 2013-04-28

• Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia: No Impact of Pre-transplant Extramedullary Disease on Outcome, 2015-04-27

• Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation - A Report from CIBMTR, 2014-10-30

• Hematopoietic Cell Transplant Comorbidity Index is predictive of survival after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma, 2013-12-14

• Autologous versus allogeneic transplantation in follicular lymphoma patients experiencing early treatment failure, 2018-04-12

• Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation, 2014-07-18

• An Analysis of the Effect of Race, Socioeconomic Status and Center Size on Unrelated NMDP Donor Outcomes: Donor Toxicities are More Common at Low Volume Bone Marrow Collection Centers, 2015-06-23

• Revised-International Staging System (R-ISS) is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma (MM)., 2018-12-21

• EBMT transplant centers with FACT-JACIE accreditation have significantly better compliance with related donor care standards, 2015-11-18

• Prognostic score and cytogenetic risk classification for chronic lymphocytic leukemia patients: Center for International Blood and Marrow Transplant Research report, 2019-06-28

• Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT, 2019-02-27

• Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission, 2017-12-15

• Low CD34 Dose is Associated with Poor Survival after Reduced Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome, 2014-06-02

• A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes, 2020-08-08

• Early Failure of Frontline Rituximab-containing Chemoimmunotherapy in Diffuse Large B-Cell Lymphoma does not Predict Futility of Autologous Hematopoietic Cell Transplantation, 2014-07-05

• Comparative analysis of calcineurin-inhibitor-based methotrexate and mycophenolate mofetil-containing regimens for prevention of Graft-versus-Host Disease after reduced intensity conditioning allogeneic transplantation, 2018-08-25

• Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival, 2012-08-10

• Autologous Hematopoietic Cell Transplantation for Male Germ Cell Tumors: Improved Outcomes Over 3 Decades, 2019-02-20

• RISK FACTORS FOR SUBSEQUENT CENTRAL NERVOUS SYSTEM (CNS) TUMORS IN PEDIATRIC ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT (HCT): A STUDY FROM THE CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH (CIBMTR), 2017-04-12

• Health-Related Quality of Life Outcomes in Older Hematopoietic Cell Transplant Survivors, 2022-11-23

• Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues, 2014-01-28

• Chimeric antigen receptor T-cell therapy: Challenges and framework of outpatient administration, 2021-11-19

• Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT, 2016-03-15

• Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues, 2014-01-10

• Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society o, 2022-05-06

• Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia, 2020-03-03

• Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma, 2014-03-15

• Community Health Status and Outcomes after Allogeneic Hematopoietic Cell Transplantation in the United States, 2020-10-21

• Time to consider HPV vaccination after allogeneic stem cell transplantation, 2010-03-17

• ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR CHEMOTHERAPY-UNRESPONSIVE MANTLE CELL LYMPHOMA: A COHORT ANALYSIS FROM THE CIBMTR, 2013-01-17

• Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemotherapy, 2011-12-24

• Avascular necrosis of bone following allogeneic hematopoietic cell transplantation in children and adolescents, 2014-01-02

• Post-transplant outcomes in high-risk compared to non-high risk multiple myeloma, a CIBMTR analysis, 2016-08-02

• Maintenance therapies for Hodgkin and non-Hodgkin lymphomas after autologous transplantation: A consensus project of ASBMT, CIBMTR and LWP-EBMT., 2019-05-01

• New indications and platforms for CAR-T therapy in lymphomas beyond DLBCL, 2021-11-23

• Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies, 2015-08-29

• Influence of age on acute and chronic GVHD in children receiving HLA-identical sibling BMT for acute leukemia: implications for prophylaxis, 2017-11-16

• Role of bridging therapy during chimeric antigen receptor T cell therapy, 2021-11-19

• Risk of Acute Myeloid Leukemia and Myelodysplastic Syndrome After Autotransplants for Lymphomas and Plasma Cell Myeloma, 2018-07-19

• Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry, 2022-06-02

• Lower GVHD and relapse risk in PTCy-based Haploidentical vs Matched Sibling Donor RIC Transplant for Hodgkin Lymphoma., 2019-05-25

• First and Second-Line Systemic Treatment of Acute Graft-versus-host Disease: Recommendations of the American Society of Blood and Marrow Transplantation, 2012-04-14

• Acute leukemia risk associated with low dose radiation, 2018-07-17

• Increased Risk of Cervical Dysplasia in Long-Term Survivors of Allogeneic Stem Cell Transplantation-Implications for Screening and HPV Vaccination, 2010-09-01

• Ocular graft-versus-host disease after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT, 2018-11-24

• Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Transplantation and Cellular Therapy, 2018-12-18

• Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields are Less, 2017-09-25